APP and Alzheimer disease: FAIM-L was found to be reduced in the hippocampus of Alzheimer’s disease patients (Carriba et al., 2015) and in the entorhinal and hippocampal cortex of Alzheimer’s disease mouse models (APP-PS1) (Carriba et al., 2015).